Clinical Trials · NCT00541047

RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery

CompletedPhase 3Gonadorelin (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
University College, London
Enrollment
4,236
Start date
Nov 2007
Locations
58 sites, Canada, United Kingdom
Primary endpoint
Disease-specific survival (i.e., death due to prostate cancer) (RADICALS-HD)
View Gonadorelin compound reference